BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 216243)

  • 1. Studies of the pathophysiology of pyruvate dehydrogenase deficiency.
    Blass JP; Gibson GE
    Adv Neurol; 1978; 21():181-9. PubMed ID: 216243
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyruvate dehydrogenase deficiency presenting as intermittent isolated acute ataxia.
    Debray FG; Lambert M; Gagne R; Maranda B; Laframboise R; MacKay N; Robinson BH; Mitchell GA
    Neuropediatrics; 2008 Feb; 39(1):20-3. PubMed ID: 18504677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-oxidative function of the pyruvate dehydrogenase complex in the brain of animals].
    Nemeria NS; Ban'kovskiĭ AA; Gorenshteĭn BI
    Dokl Akad Nauk SSSR; 1988; 298(3):750-3. PubMed ID: 3371182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of muscular pyruvate dehydrogenase in 2 experimental ataxia models].
    Butterworth RF; Izumi K; Landreville F; Barbeau A
    Union Med Can; 1977 Apr; 106(4):468-71. PubMed ID: 860338
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyruvate dehydrogenase complex in Friedreich's ataxia.
    Barbeau A; Melançon S; Butterworth RF; Filla A; Izumi K; Ngo TT
    Adv Neurol; 1978; 21():203-17. PubMed ID: 367116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic conversion of pyruvate in the liver in experimental burns].
    Slobodin VB
    Vopr Med Khim; 1981; 27(4):496-500. PubMed ID: 7293081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: effects of pyruvate dehydrogenase complex deficiency and dichloroacetate.
    Simpson NE; Han Z; Berendzen KM; Sweeney CA; Oca-Cossio JA; Constantinidis I; Stacpoole PW
    Mol Genet Metab; 2006; 89(1-2):97-105. PubMed ID: 16765624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [E2 and E3 deficiency of pyruvate dehydrogenase complex].
    Matuda S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):666-9. PubMed ID: 3152088
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency.
    Di Rocco M; Lamba LD; Minniti G; Caruso U; Naito E
    Eur J Paediatr Neurol; 2000; 4(3):115-7. PubMed ID: 10872106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of pyruvate metabolism in mammalian tissues.
    Denton RM; Halestrap AP
    Essays Biochem; 1979; 15():37-77. PubMed ID: 391551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activation of pyruvate dehydrogenase by addition of insulin to a mixture of cell membranes and mitochondria from the brain of normal and alloxan treated rats. (Preliminary note)].
    Rinaudo MT; Curto M; Bruno R
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):53-5. PubMed ID: 6367775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of the pyruvate dehydrogenase complex and of mitochondrial fatty acid oxidation.
    Bindoff LA; Birch-Machin MA; Jackson S; Singh Kler R; Bartlett K; Turnbull DM
    Rev Neurol (Paris); 1991; 147(6-7):526-31. PubMed ID: 1962058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussion: oxidative disorders.
    Adv Neurol; 1978; 21():245-56. PubMed ID: 104556
    [No Abstract]   [Full Text] [Related]  

  • 14. c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons.
    Zhou Q; Lam PY; Han D; Cadenas E
    J Neurochem; 2008 Jan; 104(2):325-35. PubMed ID: 17949412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a pyruvate dehydrogenase modulator purified from insulin-treated rat brain plasma membranes.
    Rinaudo MT; Bedino S; Curto M; Testore G; Bruno R
    Ital J Biochem; 1986; 35(4):242-58. PubMed ID: 3536796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of pyruvate oxidation by skeletal muscle mitochondria by phenylpyruvate.
    Swierczyński J; Aleksandrowicz Z; Zydowo M
    Acta Biochim Pol; 1976; 23(2-3):85-92. PubMed ID: 987681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent muscle weakness and ataxia in thiamine-responsive pyruvate dehydrogenase complex deficiency.
    Kinoshita H; Sakuragawa N; Tada H; Naito E; Kuroda Y; Nonaka I
    J Child Neurol; 1997 Feb; 12(2):141-4. PubMed ID: 9075024
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites.
    Gibson GE; Blass JP
    J Neurochem; 1976 Jun; 26(6):1073-8. PubMed ID: 945329
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of thiamine thiazolone diphosphate-induced inhibition of a pyruvate dehydrogenase complex in vitro and in intact mitochondria].
    Iakovleva GM; Strumilo SA; Gorenshteĭn BI; Ostrovskiĭ IuM
    Biokhimiia; 1986 Jan; 51(1):59-64. PubMed ID: 3955104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of pyruvate dehydrogenase complex in tissues of an eight month old infant.
    Hansikova H; Zeman J; Klement P; Technikova-Dobrova Z; Houstkova H; Houstek J; Papa S
    Biochem Mol Biol Int; 1993 Dec; 31(6):1157-66. PubMed ID: 8193600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.